Vaccination for the control of rift valley fever in enzootic and epizootic situations

Developments in Biologicals

Volumn 135, Issue , 2013, Pages 61-72

  Dungu, Baptiste ^a   Donadeu, M ^a   Bouloy, M ^b  

^a Bush Loan   (United Kingdom)

^b INSTITUT PASTEUR   (France)

Author keywords

Enzootic; Epizootic; Rift Valley fever; Vaccines

Indexed keywords

DNA VACCINE; INACTIVATED VIRUS VACCINE; LIVE VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; DISEASE CONTROL; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; LIVESTOCK; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RIFT VALLEY FEVER; SPECIES DIFFERENCE; VACCINATION; VIRUS MUTANT; VIRUS RECOMBINANT;

ANIMALS; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION SCHEDULE; RIFT VALLEY FEVER; VACCINATION; VIRAL VACCINES; WORLD HEALTH;

EID: 84880970917     PISSN: 14246074     EISSN: 16622960     Source Type: Book Series    
DOI: 10.1159/000157178     Document Type: Article

References (25)

1. Daubney R, Hudson JR, Garnham PC: Enzootic hepatitis or Rift Valley fever: An undescribed disease of sheep, cattle and man from East Africa. J Path Bact 1931; 34: 545-579.
2. Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, Hilditch C et al.: Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 1991;180: 738-753.
3. Murithi RM, Munyua P, Ithondeka PM, Macharia JM, Hightower A, Luman ET, et al: Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districts. Epidemiol Infect 2011;139 (3): 372-380.
4. Meegan JM, Hoogstraal H, Moussa MI: An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec 1979;105(6): 124-125.
5. Zeller HG, Fontenille D, Traore-Lamizana M, Thiongane Y, Digoutte JP: Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg 1997;56(3): 265-272.
6. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM: Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 2003;37: 1084-1092.
7. Hassan OA, Ahlm C, Sang R, Evander M: The 2007 Rift Valley fever Outbreak in Sudan. PLoS Negl Trop Dis 2011;5(9):e1229.
8. El Mamy AB, Baba MO, Barry Y, Isselmou K, Dia ML, El Kory MO, H, Diallo M, El Kory M, Diop M, Lo M, Thiongane Y, Bengoumi M, Puech L, Plee L, Claes F, de La Rocque S and Doumbia B: Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg Infect Dis 2011;17(10): 1894-1896.
9. Smithburn KC: Rift Valley fever: the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol 1949;30: 1-16.
10. Swanepoel R, Coetzer JAW. Rift Valley fever. In: Coetzer JAW &Tustin RC (eds). Infectious diseases of livestock; 2nd ed. South Africa: Oxford, Oxford University Press, 2004; 1037-1070.
11. Barnard BJH: Rift Valley fever vaccine: antibody and immune response in cattle to a live and inactivated vaccine. J. S. Afr. vet. Assoc. 1979; 50: 155-157.
12. Muller R, Saluzzo JF, Lopez N, Dreier T, Turrel M, Smith J, et al.: Characterization of Clone 13, a naturally attenuated avirulent isolate of RVF virus, which is altered in the small segment; Am J Trop Med Hyg 1995;53: 405-411.
13. Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, Bouloy M: Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep. Vaccine 2010;28 (June (29)): 4581-4587.
14. von Teichman B, Engelbrecht A, Zulu G, Dungu B, Pardini A, Bouloy M: Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves. Vaccine 2011;29 (August (34)): 5771-5777.
15. Botros B, Omar A, Elian K, Mohamed G, Soliman A, Salib A, Salman D, Saad M, Earhart K: Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J Med Virol. 2006 Jun;78(6): 787-91.
16. Anyamba A, Linthicum KJ, Small J, Britch SC, Pak E, de La Rocque S, Formenty P, Hightower AW, Breiman RF, Chretien JP, Tucker CJ, Schnabel D, Sang R, Haagsma K, Latham M, Lewandowski HB, Magdi SO, Mohamed MA, Nguku PM, Reynes JM, Swanepoel R: Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies. Am J Trop Med Hyg. 2010 Aug;83 (2 Suppl): 43-51.
17. Clements AC, Pfeiffer DU, Martin V, Pittliglio C, Best N, Thiongane Y: Spatial risk assessment of Rift Valley fever in Senegal; Vector Borne Zoonotic Dis. 2007 Summer;7(2): 203-16.
18. FAO: Rift Valley fever vaccine development, progress and constraints. Proceedings of the GF-TADs meeting, January 2011, Rome, Italy. FAO Animal Production and Health Proceedings, No. 12. Rome, Italy
19. Hunter P, Erasmus BJ Vorster JH: Teratogenicity of a mutagenised Rift Valley fever strain (MVP12) in sheep. Onderstepoort J. vet. Res. 2002;69 (1): 95-98.
20. Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ: Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine 2012;14;30 (23):3423-9. Epub 2012 Mar 24
21. Bird BH, Albariño CG, Hartman AL, Erickson BR, Ksiazek TG, Nichol ST Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol. 2008 Mar;82 (6):2681-91. Epub 2008 Jan 16.
22. Kortekaas J, Dekker A, de Boer SM, Weerdmeester K, Vloet RP, de Wit AA, Peeters BP, Moormann RJ Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine 2010; 28 (March 11):2271-6. Epub 2010 Jan 14.
23. Näslund J, Lagerqvist N, Habjan M, Lundkvist A, Evander M, Ahlm C, Weber F, Bucht G: Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. Virology. 2009 Mar 15;385 (2):409-415. Epub 2009 Jan 20.
24. Lorenzo G., Martín-Folgar R., Rodríguez F., Brun A.: Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep; Vaccine 2008, 26, 5255-5262
25. Lagerqvist N, Näslund J, Lundkvist A, Bouloy M, Ahlm C, Bucht G: Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs. Virol J. 2009; 6 (Jan (6))